(PRESS RELEASE) THE HAGUE, 19-Jun-2020 — /EuropaWire/ — The Dutch Research Council (NWO) has announced that six researchers will receive the highest awards in science in the Netherlands. The Spinoza Prize, emphasised on the scientific work and fundamental questions, will … Read the full press release
Posted in Awards, Financial, Healthcare, Netherlands, News, Science, Technology
Tagged Awards, Cancer, chemotherapy, DNA, Eindhoven University of Technology, immunotherapy, laureate, Leiden University, molecular biophysics, NWO, oncology, professor Jan van Hest, Professor Linda Steg, Professor Nynke Dekker, professor Pauline Kleingeld, professor Sjaak Neefjes, professor Ton Schumacher, researchers, RNA molecules, science, Spinoza Prize, Stevin Prize, TU Delft, University of Groningen
(PRESS RELEASE) STOCKHOLM, SWEDEN / SANTA BARBARA, CALIF., USA, 15-Jun-2020 — /EuropaWire/ — Palette Life Sciences, a fully integrated global life sciences company dedicated to improving patient outcomes, today announced global distribution expansion for two of Palette’s products, Deflux and … Read the full press release
Posted in Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Healthcare, Hungary, Iceland, Ireland, Italy, Luxembourg, Malta, Marketing, Netherlands, News, Norway, Pharma & Biotech, Portugal, Retail, Spain, Sweden, Switzerland, United Kingdom
Tagged Barrigel®, bladder, bowel incontinence, CJ Medical, colorectal, colorectal conditions, Danielle Hazarian, Deflux, Deflux®, dextranomer, fecal incontinence, GP Dermal, Grifols, injectable gel bulking agent, interventional oncology, James Leech, KEBOMED, kidneys, life sciences, oncology, Palette Life Sciences, pediatric, polysaccharides, RA Distribution, radiotherapy, serious pediatric urinary condition, Solesta, Solesta®, Stratarium Sarl, ureter, urine reflux, urine refluxes, urogynecology, urology, vesicoureteral reflux, VUR
ACE-CL-001 trial showed an overall response rate of 97% with a sustained safety profile for previously untreated patients after more than four years In pivotal ASCEND trial, 82% of patients with relapsed or refractory disease treated with Calquence remained progression … Read the full press release
Tecentriq in combination with Avastin is the first and only cancer immunotherapy regimen approved for the treatment of unresectable or metastatic hepatocellular carcinoma Tecentriq combination improved overall survival and progression-free survival compared to the previous standard of care Application approved … Read the full press release
(PRESS RELEASE) CAMBRIDGE, 22-May-2020 — /EuropaWire/ — Enhertu, jointly developed by British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca and the second-largest pharmaceutical company in Japan Daiichi Sankyo (Daiichi Sankyo Company, Limited), has just been granted Orphan Drug Designation (ODD) in … Read the full press release
The new immunotherapy will be tested in humans as soon as possible (PRESS RELEASE) ZURICH, 8-May-2020 — /EuropaWire/ — University of Zurich researchers have announced a study that is showing how hematopoietic stem cells from a healthy donor can help … Read the full press release
Posted in Education, Healthcare, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged acute leukemia, Acute myeloid leukemia, Alexander Simonis, AML, Antonia M. Müller, blood stem cells, bone marrow, Burkhard Becher, C. Matthias Wilk, Cancer, cancerous hematopoietic stem cells, CAR-T, chemotherapy, Chiara F. Magnani, Christian Münz, Dario Neri, Donal McHugh, ETH Zurich, genetic modification, hematology, Hematopoietic stem cells, immunotherapy, Jonathan D. Kiefer, Juliane Friemel, leukemia, Maries van den Broek, Markus G. Manz, Markus Manz, Nicolás Nuñez, Norman F. Russkamp, oncology, platelets, radiotherapy, red blood cells, Renier Myburgh, Surema Pfister, transplant, University Hospital Zurich, University of Zurich, white blood cells
San Francisco, CA, USA, 05-Nov-2018 — /EuropaWire/ — McKesson Corporation (NYSE:MCK) today announced that John H. Hammergren, chairman and chief executive officer (CEO), has decided to retire, effective March 31, 2019. McKesson’s Board of Directors has unanimously selected Brian Tyler, … Read the full press release
Posted in Healthcare, Management, Pharma & Biotech
Tagged appointment, Brian Tyler, Healthcare, John H. Hammergren, leadership, Management, McKesson, oncology, pharmacy
DUBLIN, 30-Aug-2018 — /EuropaWire/ — Trinity is launching a new, free, online course: “From Diagnosis to Survivorship: An introduction to Radiation Oncology,” from the discipline of Radiation Therapy. Starting on the 3rd of September 2018, this new free online course … Read the full press release
SOLAR-1 evaluated BYL719 plus fulvestrant vs. fulvestrant alone in HR+/HER2- advanced breast cancer patients with PIK3CA mutations who progressed on or following treatment with an aromatase inhibitor with or without a CDK4/6 inhibitor[1] Approximately 40% of HR+ advanced breast cancer … Read the full press release
Posted in Healthcare, Pharma & Biotech, Switzerland
Tagged breast_cancer, BYL719, Cancer, inhibitor, Novartis, oncology, PI3K
First phase of Singapore’s Advanced Medicine Imaging Center provides accurate and timely diagnosis of cancer, plus an education center for medical training and scientific research collaborations New treatment innovations, including radioisotope and proton beam therapies, will be made progressively available … Read the full press release
Kymriah demonstrated an overall response rate of 50%, with median duration of response not yet reached at the time of data cut-off, indicating sustainability of response[1] Kymriah is the only CAR-T therapy FDA-approved for two distinct indications – in non-Hodgkin … Read the full press release
Posted in Healthcare, Pharma & Biotech, Switzerland
Tagged CAR-T, FDA, Kymriah, leukemia, Liz Barrett, lymphoma, Novartis, oncology, Stephen J. Schuster MD, tisagenlecleucel
STOCKHOLM, 16-Jun-2017 — /EuropaWire/ — For nearly two decades researchers have sought a way to target an estrogen receptor in the hope they could improve breast cancer survival, but an article published today in Nature Communications contends that the effort … Read the full press release
Posted in Education, Healthcare, Science, Sweden, Technology
Tagged beta receptor, Cecilia Williams, estrogen, KTH, oncology
Agreement aims to enable precision diagnostics for pancreatic cancer by developing new methods* to resolve single-cell level differences within and between tumors Memorial Sloan Kettering Cancer Center will use Philips IntelliSpace Genomics platform for advanced analytics and research collaboration capabilities … Read the full press release
Outlines actions underway to accelerate launch of Entresto®, including further expansion of US primary care field force, and reinforce strong uptake of Cosentyx® Highlights leading pipeline of second generation immuno-oncology assets Confirms Sandoz on track for 10 biosimilar filings by … Read the full press release
Posted in Healthcare, Management, Pharma & Biotech, Switzerland
Tagged biosimilars, eye care, Joseph Jimenez, Novartis, oncology
16-7-2013 — /europawire.eu/ — AstraZeneca today announced that it has entered into an agreement with the University of Cambridge and Cancer Research UK for a two-year collaboration on three pre-clinical and clinical oncology projects. This agreement with world-leading medical research institutions … Read the full press release
Posted in Business, Education, Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged AstraZeneca, Babraham Institute, Cambridge University Hospitals, Cancer, cancer research, Cancer Research UK, cancers, collaboration, David Neal, medical research, Olaparib, oncology, oncology projects, pancreatic, prostate, selumetinib, Susan Galbraith, tumour mutations, University of Cambridge
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?